Charles D. Goodwin II - Aug 29, 2022 Form 4 Insider Report for Apyx Medical Corp (APYX)

Role: Chief Executive Officer, Director
Signature: s/ Charles D. Goodwin, II
Stock symbol: APYX
Transactions as of: Aug 29, 2022
Transactions value $: $70,068
Form type: 4
Date filed: 8/31/2022, 04:51 PM
Previous filing: Jan 31, 2022
Next filing: Jan 13, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	APYX	Common Stock	Purchase	$11.9K	+2K	+7.08%	$5.93	30.3K	Aug 29, 2022	Direct	F1
transaction	APYX	Common Stock	Purchase	$58.2K	+9.75K	+32.23%	$5.97	40K	Aug 29, 2022	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This transaction was executed in multiple trades at prices ranging from $5.92 to $5.93. The reported price in Column 4 is a weighted average price, rounded to the nearest hundredth. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.
F2	This transaction was executed in multiple trades at prices ranging from $5.90 to $5.99. The reported price in Column 4 is a weighted average price, rounded to the nearest hundredth. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.

Content

This transaction was executed in multiple trades at prices ranging from $5.92 to $5.93. The reported price in Column 4 is a weighted average price, rounded to the nearest hundredth. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.

This transaction was executed in multiple trades at prices ranging from $5.90 to $5.99. The reported price in Column 4 is a weighted average price, rounded to the nearest hundredth. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.